Article
FOXO3a Negatively Regulates miR-155-5p Expression to impact the proliferation and invasion of Renal Cell Carcinoma
2023-03-20
Abstract excerpt
The development of targeted therapy and biotherapy drug resistance is the major barrier in terminal Renal Cell Carcinoma (RCC) therapy. Emerging evidence revealed that FOXO3a could be regulated to suppress RCC. In this study, the regulatory mechanism of FOXO3a on miR-155 and their specific effects in the development of RCC were investigated. We found that FOXO3a was down-regulated in RCC tissues and cell lines, wh...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e31c4b4-dc37-5893-8457-4010b36a557f
- DOI
- 10.21203/rs.3.rs-2674328/v1
